NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

$ 20.50

4.7
(627)
In stock
Description

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Microorganisms, Free Full-Text

Stages in COVID-19 vaccine development: The Nemesis, the Hubris

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant

Controlled Human Infection Models To Accelerate Vaccine

Emerging concepts in the science of vaccine adjuvants

Frontiers Recent Development of Ruminant Vaccine Against Viral

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

PDF) Vaccines Against COVID-19

An Overview of Adjuvant Use

Intestinal helminth infection impairs oral and parenteral vaccine

Frontiers Factors Which Contribute to the Immunogenicity of Non

Vaccine Adjuvant Clinical Evaluation

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect